drugset / Trial / NCT01858584

Prospective, Comparative, Randomized, Controlled Trial on the Efficacy of the Treatment of Gastroesophageal Reflux Infant With Magnesium Alginate

NCT01858584 ↗

Unknown 75 enrolled Federico II University
RandomizedParallel-groupTriple-blindTreatment

Summary

The results on the efficacy of the formulations based on alginic acid are controversial. Corvaglia et al demonstrated a significant reduction in reflux episodes in preterm infants by evaluation with pH-impedance analysis. This study concludes that the use of alginic acid reduces the acidity of the gastroesophageal reflux (GER) and has a non-systemic effect and a lesser presence of side effects compared to the use of H2-receptor antagonist(H2RA) and proton pump inhibitor (PPI).

Timeline

Start
2013-02
Primary completion
2013-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Gastrotuss Unknown 2.5 ml —
Subject Gastrotuss Unknown 5 ml —